Leticia Gonçalves

President of Health and Biosciences

Inspired by nature and distinguished by creativity and innovation, IFF’s Health and Biosciences business unit partners with customers to deliver sustainable, high-performance solutions. The portfolio includes probiotics, cultures, and enzymes solutions that support health, food, and home applications. Before joining IFF, Leticia served as president of Precision Fermentation and ADM Ventures at ADM as well as a member of the company’s Executive Council. In this role, she led ADM’s global innovation strategy and execution, including oversight of its venture investment portfolio, business incubation efforts and partnerships. Previously, Leticia served as president of Global Foods, where she oversaw  food ingredients, savory, sweet goods and dairy businesses and managed a high-growth global P&L.

Leticia Gonçalves
Follow Me:

An international leader, Leticia brings deep market insight shaped by living in Europe, Brazil and the U.S., where she also led impactful, diverse teams.

Before joining IFF, Leticia served as president of Precision Fermentation and ADM Ventures at ADM as well as a member of the company’s Executive Council. In this role, she led ADM’s global innovation strategy and execution, including oversight of its venture investment portfolio, business incubation efforts and partnerships. Previously, Leticia served as president of Global Foods, where she oversaw food ingredients, savory, sweet goods and dairy businesses and managed a high-growth global P&L.

An international leader, Leticia brings deep market insight shaped by living in Europe, Brazil and the U.S., where she also led impactful, diverse teams.

Appointed President, Health & Biosciences (H&B) at IFF effective March 1, 2025, succeeding Simon Herriott; brings extensive P&L and innovation leadership across ADM, Bayer, and Monsanto.

Leads IFF’s biotechnology platform (probiotics, cultures, enzymes) focused on sustainable, high‑performance solutions for health, food, home care—aligned with IFF’s 2025 operating model.

Guided strategic partnerships that advance H&B innovation, including IFF’s 2025 collaboration with BASF to accelerate Designed Enzymatic Biomaterials™ for next‑gen enzyme and polymer solutions in home & personal care.

image (2) (1)

Education

  • Stanford University Graduate School of Business, Directors’ Consortium
  • University of Pittsburgh Katz Graduate School of Business, Executive MBA
  • USP –Universidade de São Paulo, Bachelors, Chemical Engineering
Lab Tour-10
3 (1)
Frame 14015421 1

Featured Articles

shutterstock_1634044951

Fortalecimiento de la masa en la panificación industrial: más consistencia, eficiencia y estabilidad del proceso

shutterstock_1634044951

Panificação industrial: massa mais forte, produção mais eficiente

shutterstock_2431140403

Evolução da IA ​​na produção de etanol

shutterstock_2431140403

Evolución de la IA en la producción de etanol

Blue microscopic microbiome ecosystem with rod-shaped microbes and surrounding particles, representing the human gut microbiome and the second genome.

¿Qué es el microbioma? De palabra de moda a motor biológico

Blue microscopic microbiome ecosystem with rod-shaped microbes and surrounding particles, representing the human gut microbiome and the second genome.

O que é o microbioma? De palavra da moda a motor biológico